Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia

1. Peñalver, F.J.
2. Alvarez-Larrán, A.
3. Díez-Martin, J.L.
4. Gallur, L.
5. Jarque, I.
6. Caballero, D.
7. Díaz-Mediavilla, J.
8. Bustelos, R.
9. Fernández-Aceñero, M.J.
10. Cabrera, J.R.